发明名称 Substituted triazolopyridine compounds
摘要 A compound of formula wherein R<1 >is -NR'R'', wherein R' and R'' are independently selected from the group consisting of lower alkyl, -(CH2)n-C(O)NR<a>R<b>, -(CH2)n-heteroaryl, -(CH2)n-aryl, -(CH2)n-CN, -(CH2)n-O-lower alkyl or -(CH2)n-cycloalkyl, or R' and R'' form together with the N-atom a five or six-membered non- aromatic ring, containing no or one additional heteroatom selected from the group consiting of O and S, and said ring being unsubstituted or substituted by one or two substituents, selected from the group consisting of lower alkyl, -C(O)NR<a>R<b >and -(CH2)n-O-lower alkyl, and R<a>R<b >are independently from each other hydrogen or lower alkyl; R<2 >is aryl or heteroaryl, unsubstituted or substituted by lower alkyl or halogen; and n is 0, 1, 2 or 3; or a pharmaceutically acceptable salt thereof. Compounds of formula I are useful in the treatment of disease associated with the adenosine A2 receptor.
申请公布号 US2003207911(A1) 申请公布日期 2003.11.06
申请号 US20020265957 申请日期 2002.10.07
申请人 NETTEKOVEN MATTHIAS HEINRICH;SCHMITT SEBASTIEN 发明人 NETTEKOVEN MATTHIAS HEINRICH;SCHMITT SEBASTIEN
分类号 A61K31/435;A61K31/437;A61K31/444;A61K31/4545;A61K31/5377;A61K31/541;A61P9/10;A61P11/06;A61P11/16;A61P21/02;A61P25/00;A61P25/04;A61P25/08;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P37/08;A61P43/00;C07D471/04;(IPC1-7):A61K31/474;C07D471/02 主分类号 A61K31/435
代理机构 代理人
主权项
地址